Standout Papers

Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorec... 2004 2026 2011 2018 3.8k
  1. Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer (2004)
    David Cunningham, Yves Humblet et al. New England Journal of Medicine

Immediate Impact

5 by Nobel laureates 4 from Science/Nature 139 standout
Sub-graph 1 of 12

Citing Papers

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Designed protein logic to target cells with precise combinations of surface antigens
2020 StandoutScienceNobel
2 intermediate papers

Works of M. Mueser being referenced

Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout

Author Peers

Author Last Decade Papers Cites
M. Mueser 1867 3682 184 782 18 4.4k
Florin Sirzén 2567 3491 42 810 28 5.4k
Ashley E. Winkler 2444 3862 381 1138 12 7.2k
Erika Hitre 1410 4291 84 786 59 5.4k
Ilhan Celik 1615 2782 65 731 30 3.8k
Anatoly Makhson 1886 4125 36 795 11 5.2k
Shirin Khambata‐Ford 2191 4391 55 1135 34 5.4k
Christiane Langer 1956 4496 42 1097 26 5.7k
Johannes Nippgen 1415 3151 26 769 27 4.2k
J. Załuski 1659 3637 27 559 22 4.4k
Jean-Yves Douillard 3029 3023 102 928 70 5.5k

All Works

Loading papers...

Rankless by CCL
2026